MD-117

N/A

Report date: 2025/01/26 16:25:21
NME

Base Information

Drug NameMD-117
Drug Alias NameAzonafides (Oncolinx Pharmaceuticals/National Cancer Institute at Frederick)MD-117
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA intercalators
TargetsDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncolinx Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesOncolinx Pharmaceuticals LlcNational Cancer Institute
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A